What are the top disease areas for clinical drug trials?
Drug Discovery World
FEBRUARY 20, 2023
AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone was approved in the EU for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men for whom chemotherapy is not clinically indicated. The post What are the top disease areas for clinical drug trials?
Let's personalize your content